AEON Biopharma (AEON) Tax Provisions (2022 - 2024)

AEON Biopharma (AEON) posted Tax Provisions of -$496296.0 for Q4 2024, down 641.44% sequentially from $91662.0 in Q2 2023.

AEON Biopharma (AEON) Tax Provisions (2022 - 2024) Analysis & Trends

AEON Biopharma has reported Tax Provisions for 3 years, with the latest figure at -$496296.0 in Q4 2024.

Quarterly Tax Provisions changed N/A year-over-year to -$496296.0 in Q4 2024, while the trailing twelve-month figure through Sep 2023 was $496296.0 (changed N/A YoY) and the FY2025 annual result came in at -$8.2 million, changed N/A from the prior year.
Tax Provisions eased to -$496296.0 in Q4 2024 per AEON's latest filing, from $91662.0 in the prior quarter.
Over five years, Tax Provisions peaked at $404634.0 in Q1 2023 and troughed at -$496296.0 in Q4 2024.
A 3-year average of $4241.2 and a median of $54313.5 in 2022 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 440.3% in 2023, down 440.3% in 2023.
Over 3 years, Tax Provisions stood at $16965.0 in 2022, then soared by 440.3% to $91662.0 in 2023, then slumped by 641.44% to -$496296.0 in 2024.
According to Business Quant data, Tax Provisions over the past three periods registered -$496296.0, $91662.0, and $404634.0 for Q4 2024, Q2 2023, and Q1 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	59.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	13.31 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.90 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-90.33 Mn
10	AEON Biopharma	10.06 Mn	6.62 Mn	-	-

Download Data